0001209191-22-043143.txt : 20220725 0001209191-22-043143.hdr.sgml : 20220725 20220725181808 ACCESSION NUMBER: 0001209191-22-043143 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220721 FILED AS OF DATE: 20220725 DATE AS OF CHANGE: 20220725 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Wolchko J Scott CENTRAL INDEX KEY: 0001586893 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36076 FILM NUMBER: 221104533 MAIL ADDRESS: STREET 1: C/O FATE THERAPEUTICS, INC. STREET 2: 3535 GENERAL ATOMICS COURT, SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: FATE THERAPEUTICS INC CENTRAL INDEX KEY: 0001434316 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 651311552 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 12278 SCRIPPS SUMMIT DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92131 BUSINESS PHONE: 858.875.1803 MAIL ADDRESS: STREET 1: 12278 SCRIPPS SUMMIT DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92131 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-07-21 0 0001434316 FATE THERAPEUTICS INC FATE 0001586893 Wolchko J Scott C/O FATE THERAPEUTICS, INC. 12278 SCRIPPS SUMMIT DRIVE SAN DIEGO CA 92131 1 1 0 0 President and CEO Common Stock 2022-07-21 4 M 0 30000 2.70 A 461546 D Common Stock 2022-07-21 4 S 0 10829 32.54 D 450717 D Common Stock 2022-07-21 4 S 0 19171 33.07 D 431546 D Common Stock 2022-07-22 4 M 0 6246 2.70 A 437792 D Common Stock 2022-07-22 4 S 0 2923 31.33 D 434869 D Common Stock 2022-07-22 4 S 0 2703 32.61 D 432166 D Common Stock 2022-07-22 4 S 0 620 33.28 D 431546 D Stock Option (Right to Buy) 2.70 2022-07-21 4 M 0 30000 0.00 D 2027-01-03 Common Stock 30000 6246 D Stock Option (Right to Buy) 2.70 2022-07-22 4 M 0 6246 0.00 D 2027-01-03 Common Stock 6246 0 D This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 10, 2020. Represents the weighted average sale price of the shares sold ranging from $31.82 to $32.81 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2 through 6. Represents the weighted average sale price of the shares sold ranging from $32.83 to $33.33 per share. Represents the weighted average sale price of the shares sold ranging from $30.99 to $31.74 per share. Represents the weighted average sale price of the shares sold ranging from $32.02 to $33.01 per share. Represents the weighted average sale price of the shares sold ranging from $33.03 to $33.67 per share. This option is fully vested. /s/ Cindy Tahl, as Attorney-in-Fact 2022-07-25